Latest Biotech News

Roche announced its acquisition of 89bio in a deal valued up to $3.5 billion, securing the rights to pegozafermin, an experimental treatment for metabolic dysfunction-associated steatohepatitis...

New York-based LB Pharmaceuticals successfully raised $285 million through an initial public offering on Nasdaq, marking a significant milestone in a challenging biotech funding environment. The...

Researchers have developed a novel CRISPR-based gene therapy approach aiming to treat SCN2A haploinsufficiency, a genetic cause of neurodevelopmental disorders including autism and epilepsy. The...

Scientists at Stanford University and the Arc Institute have leveraged advanced AI models to generate fully functional bacteriophage genomes, a first in the field. The study utilized a series of...

Regeneron Pharmaceuticals reported positive Phase III results for garetosmab in fibrodysplasia ossificans progressiva (FOP), a rare disease causing abnormal bone formation. The drug significantly...

The U.S. Food and Drug Administration has escalated its crackdown on misleading pharmaceutical and telehealth advertisements by releasing around 100 warning letters to firms including major...

GlaxoSmithKline announced comprehensive plans to invest $30 billion over five years to bolster U.S.-based drug manufacturing capabilities and research infrastructure. The initiative includes...

Researchers have unveiled a powerful generative AI model trained on UK Biobank data capable of forecasting the risk and timing of developing more than 1,000 diseases up to a decade in advance....

Duke University Health System is implementing a strategic blend of proprietary and commercial artificial intelligence technologies designed to ease clinicians’ administrative burdens and improve...

Scientists from the University of Southern California have developed advanced kidney organoids termed assembloids that combine nephron and collecting duct structures, achieving unprecedented...

Roche announced a $3.5 billion acquisition of biotech firm 89bio, gaining control of pegozafermin, a drug candidate targeting metabolic dysfunction-associated steatohepatitis (MASH), a liver...

Researchers at Stanford University and Arc Institute unveiled the first successful generation of complete, functional bacteriophage genomes designed by artificial intelligence. Using Evo...

Scientists have engineered new Cas9 proteins that substantially diminish unintended genomic alterations in prime editing, bolstering the precision of this promising genome-editing approach. Prime...

Researchers introduced a novel class of soft, high-density biofibers integrating multifaceted sensing and stimulation capabilities for brain-computer interfaces. Unlike traditional static neural...

Swiss researchers unveiled a fusion protein that combines tumor immune checkpoint disruption with selective immune activation to combat cancer. This bifunctional molecule simultaneously inhibits...

Arsenal Biosciences confirmed cutting 50% of its staff as the clinical-stage cell therapy startup pivots to focus resources. Despite raising $325 million and partnerships with Bristol Myers...

Scientists at the University of Southern California developed advanced kidney assembloids by merging separate organoids encompassing nephrons and collecting ducts into complex structures....

Researchers at Tulane University developed ActCRISPR-TB, a novel diagnostic assay detecting Mycobacterium tuberculosis DNA from simple tongue swabs using integrated isothermal amplification and...

Innovative artificial intelligence tools are revolutionizing biotechnology research and development through enhanced design capabilities. Stanford Medicine introduced CRISPR-GPT, an AI-powered...

Former CDC Director Susan Monarez testified before the Senate Health Committee, revealing political interference in vaccine recommendation processes by Health Secretary Robert F. Kennedy Jr. Her...